¼¼°èÀÇ ³»½Ã°æ ¿ªÇà Ãé´ã°ü Á¶¿µ¼ú(ERCP) ½ÃÀå º¸°í¼­(2025³â)
Endoscopic Retrograde Cholangiopancreatography (ERCP) Global Market Report 2025
»óǰÄÚµå : 1716972
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,253,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,039,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,824,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

³»½Ã°æ ¿ªÇà Ãé´ã°ü Á¶¿µ¼ú(ERCP) ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â¿¡´Â 8.58%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 26¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ±â°£ÀÇ ¼ºÀå ¿¹ÃøÀº ¼ÒÈ­±â ÁúȯÀÇ À¯º´·ü Áõ°¡, ¾Ï ¹ßº´·ü Áõ°¡, ÅõÀÚ ÁýÁßµµ Áõ°¡, ÃéÀå°ü Áúȯ ¹ß»ý·ü Áõ°¡, ³»½Ã°æ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ¹ß»ýÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ±â¼ú ¹ßÀü, ¿¬±¸°³¹ßÀ» À§ÇÑ ÆÄÆ®³Ê½Ê, ÇコÄɾî ÀÎÇÁ¶ó È®´ë, Á¤ºÎÀÇ ÇコÄɾî ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡, ÷´Ü ERCP Á¦Ç° °³¹ß µîÀÌ ¿¹»óµË´Ï´Ù.

À§ÀåÁúȯÀÇ À¯º´·ü Áõ°¡´Â ³»½Ã°æ ¿ªÇà Ãé´ã°ü Á¶¿µ¼ú(ERCP) ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀº ÀÔ, ½Äµµ, À§, À§, Àå, Á÷Àå, Ç×¹® ¹× °£, ´ã³¶, ÃéÀå µîÀÇ ºÎ¼Ó ±â°üÀ» Æ÷ÇÔÇÑ ¼ÒÈ­°ü(GI)¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ±¤¹üÀ§ÇÑ ÁúȯÀ» Æ÷ÇÔÇÕ´Ï´Ù. ½Ä½À°üÀÇ º¯È­, °í·ÉÈ­, Ç×»ýÁ¦ »ç¿ë, »ýȰ½À°ü, ȯ°æÀû ¿µÇâ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ ÁúȯÀÇ ¹ß»ý·üÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ERCP´Â ´ã¼®, ÇùÂø, Á¾¾ç, °¨¿°°ú °°Àº ´ã°ü ¹× ÃéÀå°üÀÇ ¹®Á¦¸¦ Áø´ÜÇϰí Ä¡·áÇϱâ À§ÇÑ Àúħ½ÀÀû ¼Ö·ç¼ÇÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ¾ÏÇÐȸ´Â 2024³â 1¿ù¿¡ ¹Ì±¹¿¡¼­ ¾à 2¸¸ 6,890°ÇÀÇ À§¾ÏÀÌ »õ·Î ¹ß»ýÇÏ¿© ¾à 1,880¸íÀÌ »ç¸ÁÇÒ °ÍÀ¸·Î Ãß»êÇϰí ÀÖ½À´Ï´Ù. À§Àå ÁúȯÀÌ º¸ÆíÈ­µÊ¿¡ µû¶ó ERCP ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä´Â °è¼Ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ERCP ½ÃÀåÀÇ ¾÷üµéÀº Áø´Ü°ú Ä¡·á¸¦ °­È­Çϱâ À§ÇØ ´ã°ü°æ ½Ã½ºÅÛ°ú °°Àº Çõ½ÅÀûÀÎ ±â¼úÀ» °³¹ßÇÏ¿© ½Ã¼ú¹ýÀ» ¹ßÀü½Ã۰í ÀÖ½À´Ï´Ù. 2024³â 7¿ù, Ææ·ÐÀº ERCP ½Ã¼úÀ» À§ÇÑ Á¤È®ÇÑ ¿µ»óÀ» Á¦°øÇÏ´Â ÃÖ÷´Ü ÀåºñÀÎ VedVision ´ã°ü°æ Á÷Á¢ ½Ã°¢È­ ½Ã½ºÅÛÀÎ VedVision ´ã°ü°æ Á÷Á¢ ½Ã°¢È­ ½Ã½ºÅÛÀ» Ãâ½ÃÇÏ¿´½À´Ï´Ù. ÀÌ ½Ã½ºÅÛ¿¡´Â 2mm ¾×¼¼¼­¸® ä³Î°ú Àü¿ë °¡À̵å¿ÍÀ̾î ä³Î, »ý°Ë °âÀÚ, °á¼® Á¦°Å ¹Ù±¸´Ï, ¼¼Æ÷ °Ë»ç ºê·¯½Ã, Æú¸³ ÀýÁ¦ ½º³×¾î¿Í °°Àº ¾×¼¼¼­¸®°¡ Æ÷ÇԵǾî Áø´Ü ¹× Ä¡·á ´É·ÂÀ» Çâ»ó½Ãŵ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½º ¿µÇâ°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Endoscopic retrograde cholangiopancreatography (ERCP) is a diagnostic and therapeutic medical procedure that integrates endoscopy with X-ray imaging to address conditions affecting the bile ducts, gallbladder, and pancreas. The process involves inserting a flexible, illuminated tube (endoscope) through the mouth into the small intestine, enabling physicians to diagnose and treat issues such as blockages or stones.

The primary products used in ERCP include endoscopes, endotherapy devices, visualization systems, and energy devices. Endoscopes are flexible tubes with a light and camera, allowing healthcare professionals to visualize the internal organs, particularly the digestive tract, during procedures such as ERCP. The procedure addresses various disease indications, including gastroesophageal reflux disease (GERD), gastrointestinal cancer, Barrett's esophagus, bile duct diseases, peptic ulcer disease, Crohn's disease, intestinal pseudo-obstruction, Ogilvie syndrome, and others. ERCP applications include biliary sphincterotomy, biliary dilatation, biliary stenting, pancreatic sphincterotomy, pancreatic duct dilatation, and pancreatic duct stenting. The key end users are hospitals and clinics, ambulatory surgery centers, and other healthcare facilities.

The endoscopic retrograde cholangiopancreatography (ERCP) market research report is one of a series of new reports from The Business Research Company that provides endoscopic retrograde cholangiopancreatography (ERCP) market statistics, including endoscopic retrograde cholangiopancreatography (ERCP) industry global market size, regional shares, competitors with endoscopic retrograde cholangiopancreatography (ERCP) market share, detailed endoscopic retrograde cholangiopancreatography (ERCP) market segments, market trends and opportunities, and any further data you may need to thrive in the endoscopic retrograde cholangiopancreatography (ERCP) industry. This endoscopic retrograde cholangiopancreatography (ERCP) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endoscopic retrograde cholangiopancreatography (ERCP) market size has grown strongly in recent years. It will grow from $1.72 billion in 2024 to $1.87 billion in 2025 at a compound annual growth rate (CAGR) of 8.87%. The growth during the historical period can be attributed to the increasing prevalence of chronic gastrointestinal diseases, expanded applications of ERCP, a rising incidence of pancreatic cancer, growing government investments, and an increase in medical tourism.

The endoscopic retrograde cholangiopancreatography (ERCP) market size is expected to see strong growth in the next few years. It will grow to $2.60 billion in 2029 at a compound annual growth rate (CAGR) of 8.58%. The growth forecast for this period is driven by the rising prevalence of gastrointestinal conditions, an increasing incidence of cancer, heightened investment focus, a growing occurrence of pancreatic duct conditions, and rising demand for endoscopes. Key trends expected include technological advancements, partnerships for research and development, the expansion of healthcare infrastructure, increased government healthcare initiatives, and the development of advanced ERCP products.

The rising prevalence of gastrointestinal conditions is anticipated to drive the growth of the endoscopic retrograde cholangiopancreatography (ERCP) market. These conditions encompass a wide range of disorders affecting the gastrointestinal (GI) tract, including the mouth, esophagus, stomach, intestines, rectum, anus, and accessory organs such as the liver, gallbladder, and pancreas. Factors such as dietary changes, an aging population, antibiotic use, lifestyle habits, and environmental influences contribute to the increasing incidence of these conditions. ERCP provides a minimally invasive solution for diagnosing and treating bile and pancreatic duct issues, including gallstones, strictures, tumors, and infections. For example, the American Cancer Society estimated in January 2024 that approximately 26,890 new cases of stomach cancer would occur in the United States, with around 10,880 deaths expected. As gastrointestinal conditions become more common, the demand for ERCP procedures continues to grow.

Companies in the ERCP market are advancing procedures by developing innovative technologies, such as cholangioscope systems, for enhanced diagnosis and treatment. These systems provide high-resolution imaging of the bile and pancreatic ducts, improving therapeutic outcomes. In July 2024, Penlon Limited introduced the VedVision Cholangioscope Direct Visualization System, a cutting-edge device offering precise imaging for ERCP procedures. Its features include a 2 mm accessory channel and a dedicated guidewire channel, along with accessories such as biopsy forceps, stone extraction baskets, cytology brushes, and polypectomy snares, enhancing diagnostic and therapeutic capabilities.

In October 2022, OmniVision Technologies Inc., a semiconductor manufacturer based in the United States, collaborated with AdaptivEndo LLC to develop a unified platform for hybrid and single-use endoscopes. This platform is designed for use across various medical specialties, including gastroenterology, hepatology, urology, and gynecology, enabling a more streamlined approach to procedures such as endoscopic retrograde cholangiopancreatography (ERCP) and other endoscopic techniques. AdaptivEndo LLC, also based in the United States, specializes in single-use endoscopy devices that combine the functionalities of endoscopic ultrasound (EUS) and ERCP, offering enhanced versatility and efficiency in clinical practice.

Major players in the endoscopic retrograde cholangiopancreatography (ERCP) market are Medtronic plc, Fujifilm Holdings Corporation, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Ottomed Endoscopy, W. L. Gore & Associates Inc., Streis plc, Cook Group, KARL STORZ SE & Co. KG, CONMED Corporation, PENTAX Medical Inc., AMBU Inc., Samsung Medison Co. Ltd., Medi-Globe GmbH, Telemed System Inc., Micro-Tech Endoscopy Inc., Hobbs Medical Inc., Shaili Endoscopy Pvt. Ltd.

North America was the largest region in the endoscopic retrograde cholangiopancreatography (ERCP) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in endoscopic retrograde cholangiopancreatography (ERCP) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the endoscopic retrograde cholangiopancreatography (ERCP) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endoscopic retrograde cholangiopancreatography (ERCP) market consists of revenues earned by entities by providing services such as diagnostic services, therapeutic services, post-operative, and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The endoscopic retrograde cholangiopancreatography (ERCP) market also includes sales of biliary stents, guidewires, and catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endoscopic Retrograde Cholangiopancreatography (ERCP) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endoscopic retrograde cholangiopancreatography (ercp) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for endoscopic retrograde cholangiopancreatography (ercp) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The endoscopic retrograde cholangiopancreatography (ercp) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Characteristics

3. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Trends And Strategies

4. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Growth Analysis And Strategic Analysis Framework

6. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Segmentation

7. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Regional And Country Analysis

8. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

9. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

10. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

11. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

12. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

13. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

14. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

15. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

16. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

17. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

18. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

19. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

20. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

21. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

22. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

23. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

24. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

25. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

26. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

27. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

28. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

29. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

30. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Competitive Landscape And Company Profiles

31. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Other Major And Innovative Companies

32. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

34. Recent Developments In The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

35. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â